Contexium

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 07 Sep 2028. This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and…

Opportunity overview

Project name
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of...

Frequently asked questions

What is Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)?

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 07 Sep 2028. This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and…

Who is funding Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)?

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) is funded by National Institutes of Health.

When is the deadline to apply for Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)?

The application deadline is 07 Sep 2028 00:00 (UTC).

Where will the Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) project take place?

The project location(s) are: United States.

How can I apply for Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.